Profound Medical (PROF) Shares Outstanding (Diluted Average) (2023 - 2026)
Profound Medical's quarterly Shares Outstanding (Diluted Average) came in at $36.3 million in Q1 2026, up 20.82% year-on-year from $30.0 million in Q1 2025, and up 20.06% quarter-over-quarter from $30.2 million in Q4 2025.
Profound Medical has reported Shares Outstanding (Diluted Average) for 4 years, with the latest figure at $36.3 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 20.82% year-over-year to $36.3 million; the trailing twelve-month figure through Mar 2026 stood at $36.3 million (up 20.82% YoY), and the FY2025 full-year result was $30.2 million, up 22.08% from the prior year.
- Shares Outstanding (Diluted Average) for Q1 2026 stood at $36.3 million, up from $30.2 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $36.3 million in Q1 2026, with the low at $2.0 million in Q1 2024.
- Average Shares Outstanding (Diluted Average) over 4 years is $23.0 million, with a median of $30.0 million recorded in 2025.
- Year-over-year, Shares Outstanding (Diluted Average) advanced 16.91% in 2024 and jumped 1384.93% in 2025.
- Tracing PROF's Shares Outstanding (Diluted Average) over 4 years: stood at $21.2 million in 2023, then increased by 16.91% to $24.8 million in 2024, then increased by 22.08% to $30.2 million in 2025, then increased by 20.06% to $36.3 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $36.3 million (Q1 2026), $30.2 million (Q4 2025), and $30.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Profound Medical | 244.28 Mn | 193.99 Mn | 3.83 Mn | 36.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.30 Mn |
| Dec 31, 2025 | 30.23 Mn |
| Sep 30, 2025 | 30.10 Mn |
| Jun 30, 2025 | 30.06 Mn |
| Mar 31, 2025 | 30.04 Mn |
| Dec 31, 2024 | 24.77 Mn |
| Jun 30, 2024 | 2.02 Mn |
| Mar 31, 2024 | 2.02 Mn |
| Dec 31, 2023 | 21.18 Mn |